Caribou Biosciences, Inc. (CRBU) Operating margin 2019–2025
Caribou Biosciences, Inc. (CRBU) operating margin by fiscal year — reported operating income divided by reported revenue.
-1329.4%FY2025 · since FY2019: -592.7% → -1329.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1329.4% | +337.8 pp |
| FY2024 | -1667.2% | -1330.5 pp |
| FY2023 | -336.6% | +431.5 pp |
| FY2022 | -768.2% | -70.3 pp |
| FY2021 | -697.8% | -405.6 pp |
| FY2020 | -292.2% | +300.5 pp |
| FY2019 | -592.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CRBU financial trends
CRBU RevenueCRBU Net incomeCRBU Net marginCRBU Gross profitCRBU Gross marginCRBU Operating incomeCRBU Operating cash flowCRBU Free cash flowCRBU Capital expendituresCRBU Return on equityCRBU Stock buybacksCRBU Dividends paidCRBU Total assetsCRBU Total liabilitiesCRBU Shareholders’ equityCRBU overview →